Ipsen SA (IPN)

82.62
+0.62(+0.76%)
  • Volume:
    130,524
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    81.54 - 82.78

IPN Overview

Prev. Close
82
Day's Range
81.54 - 82.78
Revenue
2.69B
Open
82.32
52 wk Range
65.05 - 95.9
EPS
6.52
Volume
130,524
Market Cap
6.85B
Dividend (Yield)
1.00 (1.23%)
Average Vol. (3m)
139,691
P/E Ratio
12.57
Beta
0.77
1-Year Change
22.39%
Shares Outstanding
82,964,839
Next Earnings Date
Jul 29, 2021
What is your sentiment on Ipsen SA?
or
Market is currently closed. Voting is open during market hours.

Ipsen SA News

Ipsen SA Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Ipsen SA Company Profile

Ipsen SA Company Profile

Employees
5703
Market
France

Ipsen SA is a France-based biopharmaceutical group specialized in specialty care. The Company operates globally through two segments: Specialty Care and Consumer Healthcare. In Specialty Care, the Company is focused on various therapeutic areas, including oncology, neurosciences and rare diseases. Its oncology portfolio includes Somatuline, Decapeptyl, Cabometyx and Onivyde. Its neuroscience portfolio includes Dysport, and in rare diseases key products are NutropinAq and Increlex. Its primary care portfolio includes Smecta, Forlax, Fortrans, Eziclen, and Tanakan. In oncology Ipsen focuses on a number of disease areas, which include neuroendocrine tumors, renal cell carcinoma, hepatocellular carcinoma and pancreatic cancer. In addition, the Company has specialism in neurotoxin research and operates three research and development centers located in France, the United Kingdom and the United States.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.